One-year vildagliptin, compared to placebo, treatment does not affect markers of bone resorption and calcium homeostasis in drug-naive patients with type 2 diabetes and mild hyperglycemia

M. Diamant; M. Poelma; D.L. Goede; L.W. van Golen; R.E. van Genugten; E.M. Eekhoff; A. Schweizer; R.J. Heine; J.E. Foley; G. Nijpels; M.C.M. Bunck

One-year vildagliptin, compared to placebo, treatment does not affect markers of bone resorption and calcium homeostasis in drug-naive patients with type 2 diabetes and mild hyperglycemia

M. Diamant, M. Poelma, D.L. Goede, L.W. van Golen, R.E. van Genugten, E.M. Eekhoff, A. Schweizer, R.J. Heine, J.E. Foley, G. Nijpels, M.C.M. Bunck

Research output: Contribution to journal › Meeting Abstract › Other research output

Original language	English
Pages (from-to)	A192-A193
Journal	Diabetes
Volume	59
Publication status	Published - 2010

Cite this

Diamant, M., Poelma, M., Goede, D. L., van Golen, L. W., van Genugten, R. E., Eekhoff, E. M., Schweizer, A., Heine, R. J., Foley, J. E., Nijpels, G., & Bunck, M. C. M. (2010). One-year vildagliptin, compared to placebo, treatment does not affect markers of bone resorption and calcium homeostasis in drug-naive patients with type 2 diabetes and mild hyperglycemia. Diabetes, 59, A192-A193.

@article{3052a942690541e098314a9e4d425234,

title = "One-year vildagliptin, compared to placebo, treatment does not affect markers of bone resorption and calcium homeostasis in drug-naive patients with type 2 diabetes and mild hyperglycemia",

author = "M. Diamant and M. Poelma and D.L. Goede and {van Golen}, L.W. and {van Genugten}, R.E. and E.M. Eekhoff and A. Schweizer and R.J. Heine and J.E. Foley and G. Nijpels and M.C.M. Bunck",

year = "2010",

language = "English",

volume = "59",

pages = "A192--A193",

journal = "Diabetes",

issn = "0012-1797",

publisher = "American Diabetes Association Inc.",

}

Diamant, M, Poelma, M, Goede, DL, van Golen, LW, van Genugten, RE, Eekhoff, EM, Schweizer, A, Heine, RJ, Foley, JE, Nijpels, G & Bunck, MCM 2010, 'One-year vildagliptin, compared to placebo, treatment does not affect markers of bone resorption and calcium homeostasis in drug-naive patients with type 2 diabetes and mild hyperglycemia', Diabetes, vol. 59, pp. A192-A193.

TY - JOUR

T1 - One-year vildagliptin, compared to placebo, treatment does not affect markers of bone resorption and calcium homeostasis in drug-naive patients with type 2 diabetes and mild hyperglycemia

AU - Diamant, M.

AU - Poelma, M.

AU - Goede, D.L.

AU - van Golen, L.W.

AU - van Genugten, R.E.

AU - Eekhoff, E.M.

AU - Schweizer, A.

AU - Heine, R.J.

AU - Foley, J.E.

AU - Nijpels, G.

AU - Bunck, M.C.M.

PY - 2010

Y1 - 2010

M3 - Meeting Abstract

SN - 0012-1797

VL - 59

SP - A192-A193

JO - Diabetes

JF - Diabetes

ER -